Literature DB >> 9578858

Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group.

S Moss1, R Blanks.   

Abstract

OBJECTIVES: To enable better monitoring of interim outcome measures in the NHS Breast Screening Programme by providing revised targets for cancer detection rates, and revised expected interval cancer rates. DESIGN AND
SETTING: Expected detection rates of invasive cancers at prevalent screen are calculated, using estimates of the underlying England and Wales incidence rates and age specific prevalence incidence ratios from the Swedish Two County Study. Expected interval cancer rates are also derived from this study, and are used to calculate expected detection rates at rescreening.
RESULTS: The expected invasive cancer detection rates at first screen for women aged 50-52 is 3.6 per 1000. The expected rate at rescreening for women aged 53-64 is 4.0 per 1000. Expected interval cancer rates for women screened from 1995/6 onwards are 0.45 per 1000, 0.65 per 1000, and 1.2-1.3 per 1000 for the periods within 0-<12, 12-<24, and 24-<36 months of screening.
CONCLUSIONS: The target cancer detection rates and expected interval cancer rates for the NHS Breast Screening Programme have been revised in the light of more recent data. Monitoring of the extent to which the programme is meeting these revised targets will give a more accurate indication of the potential to meet the Health of the Nation target of a 25% reduction in breast cancer mortality by the year 2000.

Entities:  

Mesh:

Year:  1998        PMID: 9578858      PMCID: PMC1756675          DOI: 10.1136/jech.52.2.111

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  13 in total

1.  Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer.

Authors:  P Prior; C B Woodman; S Wilson; A G Threlfall
Journal:  J Med Screen       Date:  1996       Impact factor: 2.136

2.  Results from the NHS breast screening programme 1990-1993.

Authors:  S M Moss; M Michel; J Patnick; L Johns; R Blanks; J Chamberlain
Journal:  J Med Screen       Date:  1995       Impact factor: 2.136

3.  Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.

Authors:  N Day; J McCann; C Camilleri-Ferrante; P Britton; G Hurst; S Cush; S Duffy
Journal:  J Med Screen       Date:  1995       Impact factor: 2.136

4.  Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations.

Authors:  D M Ikeda; I Andersson; C Wattsgård; L Janzon; F Linell
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

5.  Analysis of interval breast carcinomas in a randomized screening trial in Stockholm.

Authors:  J Frisell; G Eklund; L Hellström; A Somell
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

6.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

7.  UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening.

Authors:  N J Wald; P Murphy; P Major; C Parkes; J Townsend; C Frost
Journal:  BMJ       Date:  1995-11-04

8.  Breast cancer screening programmes: the development of a monitoring and evaluation system.

Authors:  N E Day; D R Williams; K T Khaw
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

9.  Breast screening, prognostic factors and survival--results from the Swedish two county study.

Authors:  S W Duffy; L Tabar; G Fagerberg; A Gad; O Gröntoft; M C South; N E Day
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

10.  What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial.

Authors:  L Tabár; G Faberberg; N E Day; L Holmberg
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

View more
  6 in total

1.  Risk of breast cancer in women who attend the NHS breast screening programme: cohort study.

Authors:  A G Threlfall; C B Woodman
Journal:  BMJ       Date:  2001-07-21

2.  Extending the benefits of breast cancer screening. Still hard to know how large the benefits will really be.

Authors:  U Werneke; K McPherson
Journal:  BMJ       Date:  1998-08-08

3.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.

Authors:  R G Blanks; S M Moss; C E McGahan; M J Quinn; P J Babb
Journal:  BMJ       Date:  2000-09-16

4.  Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.

Authors:  R L Bennett; S J Sellars; S M Moss
Journal:  Br J Cancer       Date:  2011-02-01       Impact factor: 7.640

5.  What should the detection rates of cancers be in breast screening programmes?

Authors:  S W Duffy; R Gabe
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

6.  Changing case Order to Optimise patterns of Performance in mammography Screening (CO-OPS): study protocol for a randomized controlled trial.

Authors:  Sian Taylor-Phillips; Matthew G Wallis; Helen Parsons; Janet Dunn; Nigel Stallard; Helen Campbell; Sarah Sellars; Ala Szczepura; Simon Gates; Aileen Clarke
Journal:  Trials       Date:  2014-01-10       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.